GB1475790A - Contraceptive method and pack - Google Patents

Contraceptive method and pack

Info

Publication number
GB1475790A
GB1475790A GB3036274A GB3036274A GB1475790A GB 1475790 A GB1475790 A GB 1475790A GB 3036274 A GB3036274 A GB 3036274A GB 3036274 A GB3036274 A GB 3036274A GB 1475790 A GB1475790 A GB 1475790A
Authority
GB
United Kingdom
Prior art keywords
daily dosage
gestagenic
gestagen
oestrogen
low
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3036274A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of GB1475790A publication Critical patent/GB1475790A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Abstract

1475790 Contraceptive method and preparation SCHERING AG 9 July 1974 [9 July 1973] 30362/74 Heading A5B A method of contraception, comprises administering to a human female on each of 10 to 12 successive days a first, low, oestrogenic daily dosage (defined) of an oestrogen and a first, low, gestagenic daily dosage (defined) of a gestagen; on each of the immediately following 11 to 9 successive days, to complete a 21-day period, a second, higher, oestrogenic daily dosage (defined) of an oestrogen and a second, higher, gestagenic daily dosage (defined) of a gestagen which is on average up to 3 times as great as the average low gestagenic daily dosage administered in the preceding 10 to 12 days, and on each of the immediately following 7 successive days, no oestrogen or gestagen, and the 28-day cycle is repeated. Oestrogens specified include 17α- ethynyl-oestradiol and oestradiol valerate. Gestagens specified include d-norgestrel, 17α- ethynyl-19-nortestosterone acetate, cyproterone acetate and 17-acetoxy-18-methyl-15α, 16α- methylene-19-nor-#<SP>4</SP>-pregnene-3, 20 dione. The dosage units may be put up as tablets or dragees on or in a suitable pack or card.
GB3036274A 1973-07-09 1974-07-09 Contraceptive method and pack Expired GB1475790A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732335265 DE2335265A1 (en) 1973-07-09 1973-07-09 METHOD OF CONTRACTION BY FOLLOWING STAGE COMBINATION PREPARATIONS

Publications (1)

Publication Number Publication Date
GB1475790A true GB1475790A (en) 1977-06-10

Family

ID=5886577

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3036274A Expired GB1475790A (en) 1973-07-09 1974-07-09 Contraceptive method and pack

Country Status (8)

Country Link
BE (1) BE817427A (en)
CA (1) CA1029302A (en)
DE (1) DE2335265A1 (en)
DK (1) DK368274A (en)
GB (1) GB1475790A (en)
NL (1) NL7409254A (en)
SE (1) SE7408956L (en)
ZA (1) ZA744412B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2365103C3 (en) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Use of hormones for contraception
DE3003036A1 (en) * 1980-01-29 1981-07-30 Irmgard von Dr.med. 5300 Bonn Kistowski AGENT FOR PREVENTING AND ELIMINATING Baldness
DE3029726A1 (en) * 1980-08-06 1982-02-25 Werner Dr.med. 4400 Münster Steinschulte Post coital contraceptive for enteral or parenteral admin. - contg. racemic norgestrel or levonorgestrel
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
DE4308406C1 (en) * 1993-03-12 1994-06-16 Jenapharm Gmbh Contraceptive compsn. with reduced hormone dose and reduced side-effects - contg. synergistic mixt. of biogenic, synthetic oestrogen and gestagen
DE4342091A1 (en) * 1993-12-09 1995-06-14 Asta Medica Ag Products for the application of initially high doses of Cetrorelix and manufacture of a combination pack for use in the treatment of diseases
DE19539233A1 (en) * 1995-10-21 1997-04-24 Klaus Dr Med Umbreit Two-phase oral contraception

Also Published As

Publication number Publication date
DE2335265A1 (en) 1975-01-30
ZA744412B (en) 1975-07-30
NL7409254A (en) 1975-01-13
DK368274A (en) 1975-03-17
BE817427A (en) 1975-01-09
CA1029302A (en) 1978-04-11
SE7408956L (en) 1975-01-10
AU7085574A (en) 1976-01-08

Similar Documents

Publication Publication Date Title
GB1490099A (en) Contraceptive method and pack
KR100187316B1 (en) Low Estrogen Oral Contraceptives
GB1433032A (en) Contraceptive method and preparations
GB2192542B (en) Combination dosage form for pre-menopausal women
FI915914A0 (en) Contraception preparation
NZ333750A (en) Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen
GB1475790A (en) Contraceptive method and pack
NZ333862A (en) Triphasic oral contraceptive method and kit comprising a combination of progestin and estrogen
Schwallie et al. Contraceptive use—Efficacy study utilizing Depo-Provera® administered as an injection once every six months
ATE249222T1 (en) BIPHASIC ORAL CONTRACEPTION METHOD AND KIT CONTAINING A COMBINATION OF PROGESTIN AND AN ESTROGEN
Haspels Post-coital oestrogen in large doses
Szontagh et al. Post-coital contraception with dienoestrol
GB1214712A (en) Contraceptive preparations
Bonner Using the pill can affect the gingiva and periodontium
IL44094A (en) Medicament pack for oral treatment with oestrogens
GB1311680A (en) Contraceptive preparations and method of contraception
Kistner Present status of oral contraceptives: 1. Effectiveness; basis for selection; side effects; metabolic changes
GB1304239A (en)
Zaki et al. Some observations on the changes in capillary resistance in oral contraceptive users
Farkas Clinical use of combined contraceptive preparations of Hungarian manufacture
CN1205639A (en) Contraceptive process and kit for female mammals, comprising combination of gestagen and oestrogen

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee